| Issue Date | Title | Author(s) |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2022-11 | Lipid-polymer nanocarrier platform enables X-ray induced photodynamic therapy against human colorectal cancer cells. | Sang, R; Deng, F; Engel, A; Goldys, E; Deng, W |
| 2022-11 | Current state of play for HPV-positive oropharyngeal cancers. | Deutsch, F; Regina Bullen, I; Nguyen, K; Tran, N-H; Elliott, M; Tran, N |
| 2022-12-15 | DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine. | Fatemi, N; Tierling, S; Es, HA; Varkiani, M; Mojarad, EN; Aghdaei, HA; Walter, J; Totonchi, M |
| 2021-03-23 | Stem cell-based approaches in cardiac tissue engineering: controlling the microenvironment for autologous cells | Augustine, R; Dan, P; Hasan, A; Khalaf, IM; Prasad, P; Ghosal, K; Gentile, C; McClements, L; Maureira, P |
| 2021-03-03 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma | Cheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021-05-03 | Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring | Lee, YYD; Nguyen, DT; Moodie, T; O’Brien, R; McMaster, A; Hickey, A; Pritchard, N; Poulsen, P; Tabaksblat, EM; Weber, B; Worm, E; Pryor, D; Chu, J; Hardcastle, N; Booth, J; Gebski, V; Wang, T; Keall, P |
| 2018-08 | MASTL overexpression promotes chromosome instability and metastasis in breast cancer. | Rogers, S; McCloy, RA; Parker, BL; Gallego-Ortega, D; Law, AMK; Chin, VT; Conway, JRW; Fey, D; Millar, EKA; O'Toole, S; Deng, N; Swarbrick, A; Chastain, PD; Cesare, AJ; Timpson, P; Caldon, CE; Croucher, DR; James, DE; Watkins, DN; Burgess, A |
| 2016-12-08 | MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. | Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
